Malachite Innovations, Inc.
Save
17.49M
Market cap
4.88x
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Malachite Innovations, Inc., together with its subsidiaries, provides health and wellness products in the United States. It offers a portfolio of approximately 100 novel cannabosides, including glycosylated tetrahydrocannabinol, cannabidiol, cannabidivarin, and cannabinol. The company also develops THC-glycoside (VBX-100), an oral prodrug for the treatment of gastrointestinal diseases, including inflammatory bowel disease and irritable bowel syndrome.

Similar securities

Based on sector and market capitalization

Report issue